stars 1 stars 2 stars 3

Pharma can measure how hard a field team works — calls, samples, coverage. What it has never been able to measure is which of those activities actually moved a prescription. That gap is the most expensive blind spot in pharmaceutical commercial operations. REVOSUITE closes it. We're an AI-powered sales enablement platform built exclusively for the pharmaceutical and nutraceutical industry. Our Rx-Booster engine turns static detail aids into interactive, AI-guided e-detailing — and connects every field interaction to the prescriptions that follow, through KPIs built for pharma rather than borrowed from generic sales software. Where legacy CRMs log activity, REVO drives outcomes: • AI that predicts where prescriptions are heading — before the sales data confirms it • Automatic flagging of risks and anomalies in field activity, before they cost a quarter • Rep enablement that lifts the whole team toward top-performer behavior • Marketing and commercial aligned on the same Rx-driven metrics The results: • 5.9M+ high-quality HCP detailing visits delivered through the platform • 510K+ prescribers actively engaged • Trusted by leading pharma and nutraceutical brands including Biocodex, Bioderma, Uriage and Vitabiotics • Live in weeks — running on top of your existing CRM, at a fraction of an enterprise rollout

REVOSUITE Questions

Mohamed Hammad is the Founder, CEO of REVOSUITE.

6 people are employed at REVOSUITE.

The NAICS codes for REVOSUITE are [53, 531].

The SIC codes for REVOSUITE are [653, 65].

Top REVOSUITE Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users